Trial of radioactive implants offers improved prostate cancer survival

Interesting and hopeful, but obviously longer term follow-up is needed. Strange to thing that radioactive implants would help to reduce cancer but I guess it is similar to conventional treatments except this approach is lower dose and more targeted.

Lead researcher Professor James Morris, from Vancouver Cancer Centre in Canada, said: “At five years follow-up, we saw a large advantage in progression-free survival in the LDR-PB group.

“Although, to date, overall survival and prostate cancer-specific survival do not appear to differ between the two groups, existing trends favour LDR-PB and an overall survival advantage is likely to emerge with longer follow-up.”